This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI GUINEA PIG IgG
catalog :
MCA561
quantity :
2 ml
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
MsGp3
product information
Entity Category :
Antibodies
Product Code :
MCA561
Description :
MOUSE ANTI GUINEA PIG IgG
Specificity :
IgG
Target Species :
Guinea Pig
Host :
Mouse
Format :
S/N
Isotypes :
IgM
Applications :
C, E
Application Types :
Immunohistology - Frozen, ELISA
Clone :
MsGp3
Quantity :
2 ml
Quantity Value :
2 ml
Quantity Type :
ml
GO Accessions :
GO:0003823, GO:0005576
GO Terms :
antibody, B cell receptor activity, extracellular, immunoglobulin, opsonin activity
Uniprot Accessions :
P01862
EntityFormats :
S/N
UNSPSC :
41116161
Product Form :
Tissue Culture Supernatant containing 0.2M Tris/HCI pH7.2
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.